Discriminative stimulus properties of NIK-247 and tetrahydroaminoacridine, centrally active cholinesterase inhibitors, in rats

This publication has 27 references indexed in Scilit:

• Evaluation of a cholinomimetic drug, 9-amino-2,3,5,6,7,8-hexahydro-1h-cyclopenta [b] quinoline (NIK-247), as an enhancer of endogenous efflux of acetylcholine from brain slices
  Neuropharmacology, 1992
• NIK-247 increases basal release of endogenous DA, 5-HT1 and NE, but not GABA, from rat brain slices.
  The Japanese Journal of Pharmacology, 1991
• TACRINE IN ALZHEIMER'S DISEASE
  The Lancet, 1989
• Tetrahydroaminoacridine selectively attenuates NMDA receptor-mediated neurotoxicity
  European Journal of Pharmacology, 1988
• Tetrahydro-9-aminoacridine (THA) interacts with the phencyclidine (PCP) receptor site
  Neuroscience Letters, 1988
• Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of alzheimer-type patients
  Brain Research, 1983
• Lisurioe inhibits 3H-spiroperidol binding to membranes isolated from striatum
  Neuropharmacology, 1978
• SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
  Published by Elsevier ,1976
• Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice
  European Journal of Pharmacology, 1976
• Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: A possible mode of action in Parkinson's disease
  European Journal of Pharmacology, 1971